Ethypharm

Allowing medical marijuana to be prescribed on the National Health Service (NHS) for chronic pain could save the national healthcare provider nearly £4 billion annually ($5.19 billion), new research reveals. The independent analysis of the economic case for prescribing medical cannabis on the NHS...

Aurora Europe GmbH, a subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB), and Ethypharm have once again been selected by the French General Directorate of Health (DGS) as exclusive suppliers of dried medical cannabis flower until the end of the French trial period. The trial has recently...

Pharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: CLVR) will soon be available for distribution by its partner in Germany, Ethypharm GmbH, a European specialty pharmaceutical company. Following a March 2021 supply agreement signed by the two companies...